{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:21:18Z","timestamp":1788448878421,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128128","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:57:05Z","timestamp":1766181425000},"page":"128128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Serotype distribution and antimicrobial resistance in pediatric invasive pneumococcal pneumonia: A Laboratory Surveillance Study from Argentina, 2022\u20132024"],"prefix":"10.1016","volume":"72","author":[{"given":"Jonathan","family":"Zintgraff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Gagetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahuel S\u00e1nchez","family":"Eluchans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alicia","family":"Moscoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Sara","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128128_bb0005","unstructured":"L\u00f3pez D, Salazar M, Del Moral I, Aurenty L. L\u00f3pez, Diana, Salazar, Marifrancy, Del Moral, Irismar, Aurenty, Lisbeth. Neumon\u00eda complicada con derrame pleural: Caracter\u00edsticas cl\u00ednicas y microbiol\u00f3gicas en pacientes pedi\u00e1tricos del Hospital de Ni\u00f1os JM de los R\u00edos. Archivos Venezolanos de Puericultura y Pediatr\u00eda 2016;79(3):86\u201391. Recuperado en 19 de marzo de 2025, de http:\/\/ve.scielo.org\/scielo.php?script=sci_arttext&pid=S0004-06492016000300002&lng=es&tlng=es. Archivos Venezolanos de Puericultura y Pediatr\u00eda [Internet]. 2016 Sept [cited 2025 Mar 19];79(3):86\u201391. Available from: http:\/\/ve.scielo.org\/scielo.php?script=sci_abstract&pid=S0004-06492016000300002&lng=es&nrm=iso&tlng=es."},{"issue":"11","key":"10.1016\/j.vaccine.2025.128128_bb0010","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jfma.2020.07.026","article-title":"Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan","volume":"119","author":"Sim","year":"2020","journal-title":"J Formosan Med Assoc"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128128_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/thoraxjnl-2020-216032","article-title":"Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia","volume":"76","author":"Strachan","year":"2021","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128128_bb0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010\u20132017: a nationwide surveillance study","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2025.128128_bb0025","unstructured":"World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper\u2013February 2019; 2019. [Internet]. [cited 2025 Mar 18]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/310968\/WER9408.pdf?sequence=1."},{"key":"10.1016\/j.vaccine.2025.128128_bb0030","doi-asserted-by":"crossref","unstructured":"Yue J, Chen L, Yao T, Du P, Gu C, Wei H, et al. A global epidemic serotype 14 Streptococcus pneumoniae switching to non-vaccine types. Hung YP, editor. Microbiol Spectr 13(5):e03151-24. [Internet]. May 6 [cited 2025 Nov 4]. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.03151-24.","DOI":"10.1128\/spectrum.03151-24"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128128_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1473-3099(24)00588-7","article-title":"Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis","volume":"25","author":"Quesada","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128128_bb0040","unstructured":"Lineamientos t\u00e9cnicos Vacunaci\u00f3n contra Neumococo. DiCEI. Ministerio de Salud de la Naci\u00f3n [Internet]. Available from: www.msal.gob.ar\/images\/stories\/bes\/graficos\/0000000947cnt-Lineamientos_neumo_adultos_WEB.pdf."},{"issue":"3","key":"10.1016\/j.vaccine.2025.128128_bb0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.vaccine.2021.12.008","article-title":"Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006\u20132019. Temporal progression of serotypes distribution and antibiotic resistance","volume":"40","author":"Zintgraff","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128128_bb0050","unstructured":"Organization WH. Manual de laboratorio para la identificaci\u00f3n y prueba de ausceptibilidad a los antimicrobianos de pat\u00f3genos bacterianos de Importancia para la aalud p\u00fablica en el mundo en desarrollo: Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, Neisseria gonorrhoeae, Salmonella serotipo Typhi, Shigella y Vibrio cholerae. 2003 [cited 2025 Mar 19]; Available from: https:\/\/iris.who.int\/handle\/10665\/69093."},{"issue":"6","key":"10.1016\/j.vaccine.2025.128128_bb0055","first-page":"699","article-title":"The quellung reaction, a neglected microbiologic technique","volume":"43","author":"Austrian","year":"1976","journal-title":"Mt Sinai J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128128_bb0060","article-title":"The Global Pneumococcal Sequencing Consortium null, Bentley SD, Page AJ, et al. SeroBA: rapid high-throughput serotyping of Streptococcus pneumoniae from whole genome sequence data","volume":"4","author":"Epping","year":"2018","journal-title":"Microb Genom"},{"key":"10.1016\/j.vaccine.2025.128128_bb0065","unstructured":"CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically approved standard - M07-11th Edition; 2018."},{"key":"10.1016\/j.vaccine.2025.128128_bb0070","series-title":"Performance standards for antimicrobial susceptibility testing. 35th ed. CLSI supplement M100","year":"2025"},{"key":"10.1016\/j.vaccine.2025.128128_bb0075","unstructured":"eucast: EUCAST [Internet]. [cited 2025 June 29]. Available from: https:\/\/www.eucast.org\/."},{"issue":"3","key":"10.1016\/j.vaccine.2025.128128_bb0080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128128_bb0085","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0836","article-title":"Pneumococcal conjugate vaccine breakthrough infections: 2001\u20132016","volume":"145","author":"Adebanjo","year":"2020","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128128_bb0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ppul.24279","article-title":"Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era","volume":"54","author":"D\u00edaz-Conradi","year":"2019","journal-title":"Pediat Pulmonol"},{"key":"10.1016\/j.vaccine.2025.128128_bb0095","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Informe regional de SIREVA II, 2020. Washington, D.C.: OPS; 2025. Disponible en: https:\/\/doi.org\/10.37774\/9789275330562. [Internet]. [cited 2025 Nov 19]. Available from: https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/69203\/9789275330562_spa.pdf?sequence=1&isAllowed=y."},{"issue":"2","key":"10.1016\/j.vaccine.2025.128128_bb0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/microorganisms12020401","article-title":"Serotype distribution and antimicrobial susceptibility pattern of Streptococcus pneumoniae in COVID-19 Pandemic Era in Brazil","volume":"12","author":"Almeida","year":"2024","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128128_bb0105","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/microorganisms9071428","article-title":"Pediatric invasive pneumococcal disease three years after PCV13 introduction in the national immunization plan\u2014the continued importance of serotype 3","volume":"9","author":"Silva-Costa","year":"2021","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128128_bb0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tim.2021.11.007","article-title":"Serotype 1 pneumococcus: epidemiology, genomics, and disease mechanisms","volume":"30","author":"Chaguza","year":"2022","journal-title":"Trends Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128128_bb0115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.vaccine.2022.12.017","article-title":"Preclinical evaluation of an investigational 21-valent pneumococcal conjugate vaccine, V116, in adult-rhesus monkey, rabbit, and mouse models","volume":"41","author":"Curry","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128128_bb0120","unstructured":"IVT-25 Pneumococcal Vaccine [Internet]. [cited 2025 Mar 25]. Available from: https:\/\/www.vax-before-travel.com\/vaccines\/ivt-25-pneumococcal-vaccine."},{"key":"10.1016\/j.vaccine.2025.128128_bb0125","unstructured":"CDC. Advisory Committee on Immunization Practices (ACIP). 2024 [cited 2025 Mar 25]. GRADE: 15-valent pneumococcal conjugate vaccine (PCV15) in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23) for adults aged \u226565 years. Available from: https:\/\/www.cdc.gov\/acip\/grade\/pneumo-PCV15-PPSV23-age-based.html."},{"key":"10.1016\/j.vaccine.2025.128128_bb0130","unstructured":"U.S. FDA Approves PREVNAR 20\u00ae, Pfizer\u2019s 20-valent Pneumococcal Conjugate Vaccine for Infants and Children | Pfizer [Internet]. [cited 2025 Mar 25]. Available from: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/us-fda-approves-prevnar-20r-pfizers-20-valent-pneumococcal."},{"issue":"12","key":"10.1016\/j.vaccine.2025.128128_bb0135","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cix115","article-title":"Pneumococcal pneumonia requiring hospitalization in US children in the 13-valent pneumococcal conjugate vaccine era","volume":"64","author":"Olarte","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128128_bb0140","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.radcr.2024.01.048","article-title":"Invasive pneumococcal disease caused by non-vaccine Streptococcus pneumoniae serotype 24B in an immunocompetent child","volume":"19","author":"Tamai","year":"2024","journal-title":"Radiol Case Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128128_bb0145","first-page":"502","article-title":"Impacto de la vacuna neumoc\u00f3cica conjugada 13-valente en la incidencia de neumon\u00eda consolidante en menores de 5 anos en el partido de Pilar, Buenos Aires: estudio de base poblacional","volume":"113","author":"Gentile","year":"2015","journal-title":"Archivos argentinos de pediatr\u00eda"},{"key":"10.1016\/j.vaccine.2025.128128_bb0150","unstructured":"nacion_cnv_2023_actualizado-18dic2024.pdf [Internet]. [cited 2025 Mar 27]. Available from: https:\/\/www.argentina.gob.ar\/sites\/default\/files\/2019\/05\/nacion_cnv_2023_actualizado-18dic2024.pdf."},{"issue":"3","key":"10.1016\/j.vaccine.2025.128128_bb0155","first-page":"219","article-title":"Esquemas atrasados de vacunaci\u00f3n y oportunidades perdidas de vacunaci\u00f3n en ni\u00f1os de hasta 24 meses: estudio multic\u00e9ntrico","volume":"109","author":"Gentile","year":"2011","journal-title":"Archivos argentinos de pediatr\u00eda"},{"issue":"Suppl. 7","key":"10.1016\/j.vaccine.2025.128128_bb0160","doi-asserted-by":"crossref","first-page":"S597","DOI":"10.1093\/cid\/ciad562","article-title":"Vaccination to reduce antimicrobial resistance burden-data gaps and future research","volume":"77","author":"Tadesse","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128128_bb0165","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1080\/21645515.2018.1476814","article-title":"The role of vaccines in fighting antimicrobial resistance (AMR)","volume":"14","author":"Jansen","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128128_bb0170","article-title":"Population genetic structure, serotype distribution and antibiotic resistance of Streptococcus pneumoniae causing invasive disease in children in Argentina","volume":"7","author":"Gagetti","year":"2021","journal-title":"Microb Genom"},{"key":"10.1016\/j.vaccine.2025.128128_bb0175","article-title":"Invasive pneumococcal disease in Argentina: a snapshot from a retrospective observational study on serotypes, antimicrobial resistance, and the potential impact of the COVID-19 pandemic (2018\u20132022)","volume":"46","author":"Zintgraff","year":"2025","journal-title":"Lancet Reg Health - Americas"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:00:30Z","timestamp":1768453230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"alternative-id":["S0264410X25014264"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128128","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotype distribution and antimicrobial resistance in pediatric invasive pneumococcal pneumonia: A Laboratory Surveillance Study from Argentina, 2022\u20132024","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128128"}}